News | December 19, 2022
Shilpa Medicare introduces cancer drug Capecitabine 1000 MG dispersible tablet
The product is backed by required scientific proof and comparative bioequivalence studies
The product is backed by required scientific proof and comparative bioequivalence studies
AUR101, with a good ADME/PK profile and high bioavailability, has demonstrated inhibition of IL-17A in whole blood from psoriasis patients
The Halol facility was placed under Import Alert by USFDA.
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Gates Frontier, Bezos Expeditions, Reliance Digital Health Limited, Greenoaks, Alumni Ventures, Moore Strategic Ventures, and Project X join ARCH as new additional investors
The company will submit an action plan on the observations and will engage with US FDA for next steps.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
This is a phase two randomized, double-blind, parallel-group, placebo and active-controlled study
LG Chem will receive totaling up to $95.5 million for the China rights
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Subscribe To Our Newsletter & Stay Updated
